B+
Bull case
20%
Probability
Target price
$70.00
Analysis reference price unavailable
Analysis 2026-03-27 · RankAlpha Sentiment AI
KOD
Kodiak SciencesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive GLOW2 topline leads to an expedited regulatory path and clear submission timeline; strong uptake expectations in the addressable diabetic retinopathy market and favorable pricing/coverage assumptions drive material upside to the anchor.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +17.5.
What can break
Commercial uptake and reimbursement uncertainty
Momentum
13
Value
41
Sentiment
90
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $42.00 · Bull $70.00 · Bear $18.00Analysis 2026-03-27; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-03-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $69.60
Why
Momentum13 · Δ7d -23.7
Value41 · Δ7d -0.0
Sentiment90 · Δ7d +17.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +17.5.
Contradictions & invalidation
- • Commercial uptake and reimbursement uncertainty
- • Insufficient cash runway or dilutive financing
- • Follow-up data or regulatory feedback raises additional evidence requirements, delaying submission and increasing cash-burn/funding risk; broader market re-rating back toward analyst median/low occurs if milestones slip.
Catalyst clock
2026-03-26
Positive topline announced from GLOW2 Phase 3 (market-moving press release / 8-K)
Lead driver: Sentiment · See AI snapshot
Momentum
13
9% active weight
Current posture
7d trendSoftening
Δ7d
-23.7
Δ21d
-73.4
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
90
62% active weight
Current posture
7d trendImproving
Δ7d
+17.5
Δ21d
+22.2
Why this grade
Composite grade A. Momentum 13.1 / Value 41.2 / Sentiment 90.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-03-27. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$42.00
Analysis reference price unavailable
Analysis 2026-03-27 · RankAlpha Sentiment AI
B-
Bear case
30%
Probability
Target price
$18.00
Analysis reference price unavailable
Analysis 2026-03-27 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.58B
Beta
2.65
Shares Out
62.85M
P/E (TTM) · Derived
-9.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-14.88
Rev YoY
-
EPS YoY
+1.8%
Gross Margin
-
Op Margin
-
Net Debt
-$50.68M
Current Ratio
2.49
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data